Drug Makers Gear Up For Round Two In Lipitor Case
Although attention has now turned to the ongoing Lipitor litigation in the United States, Ranbaxy and Pfizer will continue their U.K. battle over the blockbuster anti-cholesterol drug after Ranbaxy was cleared...To view the full article, register now.
Already a subscriber? Click here to view full article